Literature DB >> 20837646

Exercise-induced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle.

Christian Frøsig1, Christian Pehmøller, Jesper B Birk, Erik A Richter, Jørgen F P Wojtaszewski.   

Abstract

TBC1D1 is a Rab-GTPase activating protein involved in regulation of GLUT4 translocation in skeletal muscle. We here evaluated exercise-induced regulation of TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. In separate experiments healthy men performed all-out cycle exercise lasting either 30 s, 2  min or 20  min. After all exercise protocols, TBC1D1 Ser237 phosphorylation increased (∼70-230%, P < 0.005), with the greatest response observed after 20  min of cycling. Interestingly, capacity of TBC1D1 to bind 14-3-3 protein showed a similar pattern of regulation, increasing 60-250% (P < 0.001). Furthermore, recombinant 5AMP-activated protein kinase (AMPK) induced both Ser237 phosphorylation and 14-3-3 binding properties on human TBC1D1 when evaluated in vitro. To further characterize the role of AMPK as an upstream kinase regulating TBC1D1, extensor digitorum longus muscle (EDL) from whole body α1 or α2 AMPK knock-out and wild-type mice were stimulated to contract in vitro. In wild-type and α1 knock-out mice, contractions resulted in a similar ∼100% increase (P < 0.001) in Ser237 phosphorylation. Interestingly, muscle of α2 knock-out mice were characterized by reduced protein content of TBC1D1 (∼50%, P < 0.001) as well as in basal and contraction-stimulated (∼60%, P < 0.001) Ser237 phosphorylation, even after correction for the reduced TBC1D1 protein content. This study shows that TBC1D1 is Ser237 phosphorylated and 14-3-3 protein binding capacity is increased in response to exercise in human skeletal muscle. Furthermore, we show that the catalytic α2 AMPK subunit is the main (but probably not the only) donor of AMPK activity regulating TBC1D1 Ser237 phosphorylation in mouse EDL muscle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837646      PMCID: PMC3008856          DOI: 10.1113/jphysiol.2010.194811

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  34 in total

1.  Reporting ethical matters in the Journal of Physiology: standards and advice.

Authors:  Gordon B Drummond
Journal:  J Physiol       Date:  2009-02-15       Impact factor: 5.182

2.  Regulation of glucose transporter 4 translocation by the Rab guanosine triphosphatase-activating protein AS160/TBC1D4: role of phosphorylation and membrane association.

Authors:  Jacqueline Stöckli; Jonathan R Davey; Cordula Hohnen-Behrens; Aimin Xu; David E James; Georg Ramm
Journal:  Mol Endocrinol       Date:  2008-09-18

3.  Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators.

Authors:  Shuai Chen; Jane Murphy; Rachel Toth; David G Campbell; Nick A Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2008-01-15       Impact factor: 3.857

4.  Contraction-stimulated glucose transport in rat skeletal muscle is sustained despite reversal of increased PAS-phosphorylation of AS160 and TBC1D1.

Authors:  Katsuhiko Funai; Gregory D Cartee
Journal:  J Appl Physiol (1985)       Date:  2008-09-25

5.  TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle.

Authors:  Ding An; Taro Toyoda; Eric B Taylor; Haiyan Yu; Nobuharu Fujii; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

6.  Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle.

Authors:  Christian Pehmøller; Jonas T Treebak; Jesper B Birk; Shuai Chen; Carol Mackintosh; D Grahame Hardie; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

7.  Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle.

Authors:  Katsuhiko Funai; George G Schweitzer; Naveen Sharma; Makoto Kanzaki; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-12       Impact factor: 4.310

8.  Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation.

Authors:  Jose A Chavez; William G Roach; Susanna R Keller; William S Lane; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

9.  Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle.

Authors:  Katsuhiko Funai; Gregory D Cartee
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  AMPK alpha1 activation is required for stimulation of glucose uptake by twitch contraction, but not by H2O2, in mouse skeletal muscle.

Authors:  Thomas E Jensen; Peter Schjerling; Benoit Viollet; Jørgen F P Wojtaszewski; Erik A Richter
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more
  29 in total

Review 1.  Of mice and men: filling gaps in the TBC1D1 story.

Authors:  Gregory D Cartee
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

2.  Acute exercise and physiological insulin induce distinct phosphorylation signatures on TBC1D1 and TBC1D4 proteins in human skeletal muscle.

Authors:  Jonas T Treebak; Christian Pehmøller; Jonas M Kristensen; Rasmus Kjøbsted; Jesper B Birk; Peter Schjerling; Erik A Richter; Laurie J Goodyear; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2013-11-18       Impact factor: 5.182

3.  Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise.

Authors:  Dorte E Kristensen; Peter H Albers; Clara Prats; Otto Baba; Jesper B Birk; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

4.  AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise.

Authors:  Hayley M O'Neill; Stine J Maarbjerg; Justin D Crane; Jacob Jeppesen; Sebastian B Jørgensen; Jonathan D Schertzer; Olga Shyroka; Bente Kiens; Bryce J van Denderen; Mark A Tarnopolsky; Bruce E Kemp; Erik A Richter; Gregory R Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

5.  Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease.

Authors:  M A Lim; M A Selak; Z Xiang; D Krainc; R L Neve; B C Kraemer; J L Watts; R G Kalb
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

6.  Ablating the protein TBC1D1 impairs contraction-induced sarcolemmal glucose transporter 4 redistribution but not insulin-mediated responses in rats.

Authors:  Jamie Whitfield; Sabina Paglialunga; Brennan K Smith; Paula M Miotto; Genevieve Simnett; Holly L Robson; Swati S Jain; Eric A F Herbst; Eric M Desjardins; David J Dyck; Lawrence L Spriet; Gregory R Steinberg; Graham P Holloway
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

7.  In vitro and in silico antidiabetic activity of pyran ester derivative isolated from Tragia cannabina.

Authors:  Vaiyapuri Sivajothi; Shruthi Shirur Dakappa
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

8.  PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.

Authors:  Thomas E Jensen; Fiona A Ross; Maximilian Kleinert; Lykke Sylow; Jonas R Knudsen; Graeme J Gowans; D Grahame Hardie; Erik A Richter
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

9.  Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).

Authors:  Anne Kosfeld; Martin Kreuzer; Christoph Daniel; Frank Brand; Anne-Kathrin Schäfer; Alexandra Chadt; Anna-Carina Weiss; Vera Riehmer; Cécile Jeanpierre; Michael Klintschar; Jan Hinrich Bräsen; Kerstin Amann; Lars Pape; Andreas Kispert; Hadi Al-Hasani; Dieter Haffner; Ruthild G Weber
Journal:  Hum Genet       Date:  2015-11-16       Impact factor: 4.132

10.  Sustained AS160 and TBC1D1 phosphorylations in human skeletal muscle 30 min after a single bout of exercise.

Authors:  M H Vendelbo; A B Møller; J T Treebak; L C Gormsen; L J Goodyear; J F P Wojtaszewski; J O L Jørgensen; N Møller; N Jessen
Journal:  J Appl Physiol (1985)       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.